Me2080 (stiripentol)    (DrugBank: Stiripentol)

1 disease
告示番号疾患名(ページ内リンク)臨床試験数
140ドラベ症候群1

140. ドラベ症候群 [臨床試験数:83,薬物数:54(DrugBank:13),標的遺伝子数:48,標的パスウェイ数:62
Searched query = "Dorabe syndrome", "Dravet syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 83 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1JPRN-JapicCTI-101116
01/4/201028/04/2010Open Phase III Study of ME2080 in Patients with Dravet SyndromeOpen Phase III Study of ME2080 in Patients with Dravet Syndrome Dravet SyndromeIntervention name : ME2080 (stiripentol)
Dosage And administration of the intervention : 50mg/kg/day administered twice or 3 times a day (maximum 2500mg/day)
Meiji Seika Pharma Co., Ltd. (formerly MEIJI SEIKA KAISHA Co., LTD.)NULL130BOTH25Phase 3NULL